These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2120306)

  • 1. Torsades de pointe with flecainide-amiodarone therapy.
    Andrivet P; Beaslay V; Canh VD
    Intensive Care Med; 1990; 16(5):342-3. PubMed ID: 2120306
    [No Abstract]   [Full Text] [Related]  

  • 2. Amiodarone and torsades de pointes.
    Jorens PG; Van den Heuvel PA; Parizel GA
    Am Heart J; 1990 Dec; 120(6 Pt 1):1482. PubMed ID: 2104037
    [No Abstract]   [Full Text] [Related]  

  • 3. Amiodarone-induced torsades de pointes: the possible facilitatory role of digoxin.
    Bajaj BP; Baig MW; Perrins EJ
    Int J Cardiol; 1991 Nov; 33(2):335-7. PubMed ID: 1743800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flecainide induced ventricular tachycardia (torsades de pointes).
    Thevenin J; Da Costa A; Roche F; Romeyer C; Messier M; Isaaz K
    Pacing Clin Electrophysiol; 2003 Sep; 26(9):1907-8. PubMed ID: 12930510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone induced torsades de pointes with excessive QT dispersion following quinidine induced polymorphic ventricular tachycardia.
    Tran HT; Chow MS; Kluger J
    Pacing Clin Electrophysiol; 1997 Sep; 20(9 Pt 1):2275-8. PubMed ID: 9309756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ['Cardiac ballet' with and without amiodarone].
    Balestra B; Hess T
    Schweiz Med Wochenschr; 1993 Jan; 123(1-2):20-5. PubMed ID: 8421775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsades de pointes ventricular tachycardia induced by mosapride and flecainide in the presence of hypokalemia.
    Ohki R; Takahashi M; Mizuno O; Fujikawa H; Mitsuhashi T; Katsuki T; Ikeda U; Shimada K
    Pacing Clin Electrophysiol; 2001 Jan; 24(1):119-21. PubMed ID: 11227957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serious QT interval prolongation with ranolazine and amiodarone.
    Tarapués M; Cereza G; Arellano AL; Montané E; Figueras A
    Int J Cardiol; 2014 Mar; 172(1):e60-1. PubMed ID: 24424337
    [No Abstract]   [Full Text] [Related]  

  • 9. Early proarrhythmia during intravenous amiodarone treatment.
    Tomcsányi J; Merkely B; Tenczer J; Papp L; Karlócai K
    Pacing Clin Electrophysiol; 1999 Jun; 22(6 Pt 1):968-70. PubMed ID: 10392400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
    Skanes AC; Morton BC; Green MS; Tang AS
    Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsade de pointes occurring early during oral amiodarone treatment.
    Faggiano P; Gardini A; D'Aloia A; Benedini G; Giordano A
    Int J Cardiol; 1996 Jul; 55(2):205-8. PubMed ID: 8842793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Torsade de pointes during anti-arrhythmia treatment with amiodarone].
    Schlienger RG; Haefeli WE; Lüscher TF
    Schweiz Rundsch Med Prax; 1993 Feb; 82(6):173-5. PubMed ID: 7679520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torsades de pointes and QT prolongation due to a combination of loratadine and amiodarone.
    Atar S; Freedberg NA; Antonelli D; Rosenfeld T
    Pacing Clin Electrophysiol; 2003 Mar; 26(3):785-6. PubMed ID: 12698686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes.
    Lehtonen A; Fodstad H; Laitinen-Forsblom P; Toivonen L; Kontula K; Swan H
    Heart Rhythm; 2007 May; 4(5):603-7. PubMed ID: 17467628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
    Makai A; Rudas L; Liszkai G; Fazekas T
    Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone-induced torsade de pointes in a patient with wolff-Parkinson-White syndrome.
    Badshah A; Mirza B; Janjua M; Nair R; Steinman RT; Cotant JF
    Hellenic J Cardiol; 2009; 50(3):224-6. PubMed ID: 19465366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone and torsades de pointes in patients with advanced heart failure.
    Middlekauff HR; Stevenson WG; Saxon LA; Stevenson LW
    Am J Cardiol; 1995 Sep; 76(7):499-502. PubMed ID: 7653452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intermittent atrial fibrillation. An "idiopathic" emergency. Torsade de pointes].
    Stiefelhagen P
    MMW Fortschr Med; 2001 Sep; 143(37):51-2. PubMed ID: 11599294
    [No Abstract]   [Full Text] [Related]  

  • 19. Amiodarone-induced torsade de pointes in a child with dilated cardiomyopathy.
    Silvetti MS; Drago F; Bevilacqua M; Ragonese P
    Ital Heart J; 2001 Mar; 2(3):231-6. PubMed ID: 11305536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torsade-de-pointes in a patient under flecainide treatment, an unusual case of proarrhythmicity.
    Nogales Asensio JM; Moreno Sánchez N; Doncel Vecino LJ; Villar Mariscal C; López-Mínguez JR; Merchán Herrera A
    Int J Cardiol; 2007 Jan; 114(2):E65-7. PubMed ID: 17056139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.